Podcast Episode 6
Measuring the Impact of Medical Affairs

October 19, 2020 / 00:17:29

Medical Affairs Unscripted logo

About this Podcast Episode

Measuring the impact of the Medical Affairs (MA) organization is not as straightforward as it is for other functions (e.g., increase in revenue or market share for Commercial) and remains a challenge for most pharmaceutical companies today. There have historically been no simple metrics to evaluate the influence of MA, so our host Peg Crowley-Nowick, PhD, MBA, Founder & President of Zipher Medical Affairs met with Meg Heim, RN, MBA, previously Vice President, Global Head of Scientific Engagement Strategy, Operations and Program Management at Sanofi and currently President at Heim Global Consulting, to discuss a methodology she developed and employed to truly measure the effectiveness of the Medical Affairs (MA) organization.

After briefly touching on Meg’s experience in advocacy and policy and its importance in advancing MA, Dr. Crowley-Nowick asks Meg to explain what MA has to do to demonstrate impact. The conversation focused on how to measure impact over time and ensure that this resonates throughout an organization. Additionally, Meg addresses the importance of working with vendor partners to fill in gaps in expertise and to provide support services that can prove to be incredibly valuable for insights, decision making, and refining strategy (e.g., data on key opinion leaders). This sixth episode of Zipher’s Medical Affairs Unscripted closes with how to use artificial intelligence to analyze insights to avoid bias and advance medical strategy.

Guest Speaker

Dr. Zhen Su, MBA, Senior Vice President and Global Head of Oncology, Merck KGaA

Meg Heim, RN, MBA
President at Heim Global Consulting
Previously Vice President, Global Head of Scientific Engagement Strategy, Operations and Program Management at Sanofi

More Podcast Episodes

Podcast Episode 5
Medical Affairs as a Strategic Equal and Maximizing a Virtual Launch

March 23, 2021 / 00:32:53

Episode Guest
Zhen Su, MD, MBA

Senior Vice President and Global Head of the Oncology Franchise for Merck KGaA, Darmstadt, Germany

Podcast Episode 4.5
Internal Edition | Building a Comprehensive Data Generation Program

October 19, 2020 / 00:17:29

Episode Guest
Julie Cahill, M.D.

Vice President of Consulting and Medical Director Services

Podcast Episode 4
Data Generation: The Intersection Between Medical Affairs and Clinical Development

September 29, 2020 / 00:46:33

Episode Guest
Dr. Adam Schayowitz

Vice President and Medicine Team Lead at Pfizer


Subscribe to our contact list for updates on our podcast series, white papers, and thought leadership e-publications.